Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
L345922-25μg | 25μg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $819.90 | |
L345922-50μg | 50μg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $1,319.90 |
a trihydroxy fatty acid produced through 15-HETE metabolism
Synonyms | (7E,9E,11Z,13E)-(5S,6R,15S)-5,6,15-Trihydroxyicosa-7,9,11,13-tetraenoate | GTPL1034 | 7,9,11,13-Eicosatetraenoic acid, 5,6,15-trihydroxy-, (5S,6R,7E,9E,11Z,13E,15S)- | F7C6J3D79J | NCGC00161280-03 | (5S,6R,7E,9E,11Z,13E,15S)-5,6,15-trihydroxyeicosa-7,9,11 |
---|---|
Specifications & Purity | Moligand™, ≥95%, 100µg/ml in ethanol |
Biochemical and Physiological Mechanisms | Lipoprotein A4 (LXA4) is synthesized from arachidonic acid and is an endogenous lipoxygenase derived arachidonic acid mediator. It is an effective activator of human protein kinase C. It inhibits the cytotoxicity of natural killer cells. LXA4 regulates th |
Storage Temp | Argon charged,Store at -80°C |
Shipped In | Ice chest + Ice pads |
Grade | Moligand™ |
Action Type | AGONIST |
Mechanism of action | Agonist of FPR2/ALX;Agonist of FPR3;Agonist of GPR32 |
Note | Store as supplied at -80° C for up to 1 year. |
Product Description |
Lipoxin A4 (LXA4), an endogenous lipoxygenase-derived eicosanoid mediator, has potent dual pro-resolving and anti-inflammatory properties. Lipoxin A4 inhibits proliferation and inflammatory cytokine/chemokine production of human epidermal keratinocytes (NHEKs) associated with the ERK1/2 and NF-kB pathways. Lipoxin A4 inhibits serum amyloid A (SAA)-mediated IL-8 release with an IC50 value of 25.74 nM.
|
pKa | pKa: 4.67 |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
IUPAC Name | (5S,6R,7E,9E,11Z,13E,15S)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoic acid |
---|---|
INCHI | InChI=1S/C20H32O5/c1-2-3-8-12-17(21)13-9-6-4-5-7-10-14-18(22)19(23)15-11-16-20(24)25/h4-7,9-10,13-14,17-19,21-23H,2-3,8,11-12,15-16H2,1H3,(H,24,25)/b6-4-,7-5+,13-9+,14-10+/t17-,18+,19-/m0/s1 |
InChi Key | IXAQOQZEOGMIQS-SSQFXEBMSA-N |
Canonical SMILES | CCCCCC(C=CC=CC=CC=CC(C(CCCC(=O)O)O)O)O |
Isomeric SMILES | CCCCC[C@@H](/C=C/C=C\C=C\C=C\[C@H]([C@H](CCCC(=O)O)O)O)O |
WGK Germany | 2 |
PubChem CID | 5280914 |
Molecular Weight | 352.47 |
PubChem CID | 5280914 |
---|---|
ChEMBL Ligand | CHEMBL392438 |
CAS Registry No. | 89663-86-5 |
ChEBI | CHEBI:6498 |
GPCRdb Ligand | LXA4 |
Enter Lot Number to search for COA:
Solubility | Soluble in ethanol, DMSO (≥50 mg/ml), DMF (≥50 mg/ml), and PBS (pH 7.2) (≥1 mg/ml). |
---|---|
Refractive Index | n20D1.54 |
Boil Point(°C) | 78° C |
Signal | Danger |
---|---|
Hazard Statements | H319:Causes serious eye irritation H225:Highly Flammable liquid and vapor |
Precautionary Statements | P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do - continue rinsing. P280:Wear protective gloves/protective clothing/eye protection/face protection. P210:Keep away from heat, hot surface, sparks, open flames and other ignition sources. - No smoking. P403+P235:Store in a well-ventilated place. Keep cool. P337+P313:IF eye irritation persists: Get medical advice/attention. |
WGK Germany | 2 |
RIDADR | UN1170-class3-PG2-Ethanol,solution |